These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 34323839)

  • 1. Current and future perspectives for wastewater-based epidemiology as a monitoring tool for pharmaceutical use.
    Boogaerts T; Ahmed F; Choi PM; Tscharke B; O'Brien J; De Loof H; Gao J; Thai P; Thomas K; Mueller JF; Hall W; Covaci A; van Nuijs ALN
    Sci Total Environ; 2021 Oct; 789():148047. PubMed ID: 34323839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is the reliability of wastewater-based epidemiology affected by season? Comparative analysis with pharmaceuticals prescriptions.
    Carnevale Miino M; Macsek T; Halešová T; Chorazy T; Hlavínek P
    Environ Sci Pollut Res Int; 2024 Mar; 31(11):16426-16436. PubMed ID: 38316739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current state and future perspectives on de facto population markers for normalization in wastewater-based epidemiology: A systematic literature review.
    Boogaerts T; Van Wichelen N; Quireyns M; Burgard D; Bijlsma L; Delputte P; Gys C; Covaci A; van Nuijs ALN
    Sci Total Environ; 2024 Jul; 935():173223. PubMed ID: 38761943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Showcasing the potential of wastewater-based epidemiology to track pharmaceuticals consumption in cities: Comparison against prescription data collected at fine spatial resolution.
    Escolà Casas M; Schröter NS; Zammit I; Castaño-Trias M; Rodriguez-Mozaz S; Gago-Ferrero P; Corominas L
    Environ Int; 2021 May; 150():106404. PubMed ID: 33578067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exposure to environmental pollutants: A mini-review on the application of wastewater-based epidemiology approach.
    Aghaei M; Khoshnamvand N; Janjani H; Dehghani MH; Karri RR
    J Environ Health Sci Eng; 2024 Jun; 22(1):65-74. PubMed ID: 38887772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Wastewater surveillance for 168 pharmaceuticals and metabolites in a WWTP: Occurrence, temporal variations and feasibility of metabolic biomarkers for intake estimation.
    Duan L; Zhang Y; Wang B; Yu G; Gao J; Cagnetta G; Huang C; Zhai N
    Water Res; 2022 Jun; 216():118321. PubMed ID: 35339048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wastewater-based epidemiology for illicit drugs: A critical review on global data.
    Huizer M; Ter Laak TL; de Voogt P; van Wezel AP
    Water Res; 2021 Dec; 207():117789. PubMed ID: 34731667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimating population-level of alcohol, tobacco and morphine use in a small Russian region using wastewater-based epidemiology.
    Rozhanets VV; Thai PK; Silantyev AS; Gandlevskiy NA; Connor JP; Eganov AA; Jang M; Pirogov AV; Shpigun OA; Priadka A; Nosyrev AE
    Drug Alcohol Rev; 2021 Nov; 40(7):1186-1194. PubMed ID: 34105188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "Waste Not, Want Not" - Leveraging Sewer Systems and Wastewater-Based Epidemiology for Drug Use Trends and Pharmaceutical Monitoring.
    Erickson TB; Endo N; Duvallet C; Ghaeli N; Hess K; Alm EJ; Matus M; Chai PR
    J Med Toxicol; 2021 Oct; 17(4):397-410. PubMed ID: 34402038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mass spectrometric strategies for the investigation of biomarkers of illicit drug use in wastewater.
    Hernández F; Castiglioni S; Covaci A; de Voogt P; Emke E; Kasprzyk-Hordern B; Ort C; Reid M; Sancho JV; Thomas KV; van Nuijs ALN; Zuccato E; Bijlsma L
    Mass Spectrom Rev; 2018 May; 37(3):258-280. PubMed ID: 27750373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Searching for the correlations between the use of different groups of pharmaceuticals from wastewaters.
    Bodík M; Mackuľak T; Feher M; Staňová AV; Grabicová K; Varjúová D; Bodík I
    Ecotoxicol Environ Saf; 2021 Nov; 228():112973. PubMed ID: 34794023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spatial variations in the consumption of illicit stimulant drugs across Australia: A nationwide application of wastewater-based epidemiology.
    Lai FY; O'Brien J; Bruno R; Hall W; Prichard J; Kirkbride P; Gartner C; Thai P; Carter S; Lloyd B; Burns L; Mueller J
    Sci Total Environ; 2016 Oct; 568():810-818. PubMed ID: 27267725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating the impact of COVID-19 countermeasures on alcohol consumption through wastewater-based epidemiology: A case study in Belgium.
    Boogaerts T; Bertels X; Pussig B; Quireyns M; Toebosch L; Van Wichelen N; Dumitrascu C; Matheï C; Lahousse L; Aertgeerts B; De Loof H; Covaci A; van Nuijs ALN
    Environ Int; 2022 Dec; 170():107559. PubMed ID: 36209600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of Illicit Drug Consumption by Wastewater Analysis Using Polar Organic Chemical Integrative Sampler as a Monitoring Tool.
    Hahn RZ; Augusto do Nascimento C; Linden R
    Front Chem; 2021; 9():596875. PubMed ID: 33859973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A global systematic review and meta-analysis on illicit drug consumption rate through wastewater-based epidemiology.
    Zarei S; Salimi Y; Repo E; Daglioglu N; Safaei Z; Güzel E; Asadi A
    Environ Sci Pollut Res Int; 2020 Oct; 27(29):36037-36051. PubMed ID: 32594443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A revised excretion factor for estimating ketamine consumption by wastewater-based epidemiology - Utilising wastewater and seizure data.
    Du P; Zheng Q; Thomas KV; Li X; Thai PK
    Environ Int; 2020 May; 138():105645. PubMed ID: 32203805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Source discrimination of drug residues in wastewater: The case of salbutamol.
    Depaolini AR; Fattore E; Cappelli F; Pellegrino R; Castiglioni S; Zuccato E; Fanelli R; Davoli E
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Jun; 1023-1024():62-7. PubMed ID: 27200473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Refining the correction factor for a better monitoring of antidepressant use by wastewater-based epidemiology: A case study of amitriptyline.
    Zhao Z; Zheng Q; Tscharke BJ; Ahmed F; O'Brien JW; Gao J; Covaci A; Thai PK
    Sci Total Environ; 2024 May; 926():172057. PubMed ID: 38552972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Framework for Public Health Authorities to Evaluate Health Determinants for Wastewater-Based Epidemiology.
    Eaton CJ; Coxon S; Pattis I; Chappell A; Hewitt J; Gilpin BJ
    Environ Health Perspect; 2022 Dec; 130(12):125001. PubMed ID: 36520537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Key Interpretation Challenges for Wastewater-Based Epidemiology of Illicit Drugs: A Norwegian Three-City Case Study.
    Bretteville-Jensen AL; Amundsen EJ; Mounteney J
    Eur Addict Res; 2022; 28(6):436-445. PubMed ID: 36137511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.